StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson TRACLEER [reported separately through FY2019Q4] by Quarter

TRACLEER (bosentan) [reported separately through FY2019Q4] — U.S. sales ($M) ($M)

Johnson & Johnson TRACLEER [reported separately through FY2019Q4]: $10M in Q4 2019, down 83.3% from a year earlier. No newer figure appears in the documents we track.

Latest, Q4 2019
10
Period ended Dec 29, 2019
Change on a year earlier
-83.3%
60 in Q4 2018
History
12 quarters
Since Q1 2017
Sources
8
Documents cited below

Where the Q4 2019 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2020-02-18) ↗

Reported in Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTRACLEER (bosentan) [reported separately through FY2019Q4] — U.S. sales ($M) ($M)Year on yearSource
Q4 2019Dec 29, 201910-83.3%Form 10-K (filed 2020-02-18) ↗
Q3 2019Sep 29, 201919-72.5%Form 10-Q (filed 2019-10-28) ↗
Q2 2019Jun 30, 201941-42.3%Form 10-Q (filed 2019-07-29) ↗
Q1 2019Mar 31, 201961-10.3%Form 10-Q (filed 2019-05-01) ↗
Q4 2018Dec 30, 201860-21.1%Form 10-K (filed 2019-02-20) ↗
Q3 2018Sep 30, 201869-16.9%Form 10-Q (filed 2018-10-31) ↗
Q2 2018Jul 1, 201871+3,450.0%Form 10-Q (filed 2018-08-02) ↗
Q1 2018Apr 1, 201868–Form 10-Q (filed 2019-05-01) ↗
Q4 2017Dec 31, 201776–Form 10-K (filed 2019-02-20) ↗
Q3 2017Oct 1, 201783–Form 10-Q (filed 2018-10-31) ↗
Q2 2017Jul 2, 20172–Form 10-Q (filed 2018-08-02) ↗
Q1 2017Apr 2, 20170–Form 10-Q (filed 2018-05-01) ↗

Breakdown

What makes up TRACLEER [reported separately through FY2019Q4]

Cite this data

StockData. (2026). Johnson & Johnson TRACLEER [reported separately through FY2019Q4] ($M), quarterly Q1 2017–Q4 2019 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug-tracleer-us

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.